Claybrook Capital’s AB InBev BUD Stock Holding History

Claybrook Capital’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,950	Closed	-$456K	–	89
2019 Q4	$456K	Sell	5,950 -950	-14%	-$79.1K	0.21%	79
2019 Q3	$657K	Hold	6,900	–	–	0.34%	65
2019 Q2	$611K	Hold	6,900	–	–	0.32%	66
2019 Q1	$579K	Buy	6,900 +6,780	+5,650%	+$521K	0.3%	68
2018 Q4	$8K	Sell	120 -13,380	-99%	-$1.02M	﹤0.01%	508
2018 Q3	$1.18M	Buy	13,500 +1,400	+12%	+$136K	0.69%	46
2018 Q2	$1.22M	Hold	12,100	–	–	0.76%	43
2018 Q1	$1.33M	Hold	12,100	–	–	0.87%	34
2017 Q4	$1.35M	Buy	+12,100	New	+$1.42M	0.96%	28

Other funds holding BUD

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCF

BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Claybrook Capital's BUD Position: Q1 2020 in Review

Claybrook Capital sold out of AB InBev (BUD) in Q1 2020, closing a stake of 5,950 shares — an estimated $456K sold.

Claybrook Capital first reported a position in BUD in Q4 2017 and held it in 9 quarters. The position peaked at $1.35M in Q4 2017. 453 funds tracked by Wall St. Rank hold BUD as of Q1 2020.

Claybrook Capital reported no remaining AB InBev position as of Q1 2020 after selling out during the quarter.
Claybrook Capital sold 5,950 AB InBev shares in Q1 2020, an estimated $456K.
Claybrook Capital first reported a position in AB InBev in Q4 2017 and held it in 9 quarters.
Claybrook Capital's AB InBev position peaked at $1.35M in Q4 2017.
453 funds tracked by Wall St. Rank held AB InBev as of Q1 2020.

Based on Claybrook Capital's 13F filing for Q1 2020, filed 5 May 2020.